Entrada Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
Entrada Therapeutics, Inc.‘s stocks are currently a part of 25 hedge funds’ portfolios, which represents 24.03% of the total amount of its stocks outstanding. This makes up a total of 7.51M shares of Entrada Therapeutics, Inc.. Compared to the previous quarter, the number fell by -69.58% or -17.19M shares fewer. As for the holding position changes, 48% (12) of current hedge fund investors increased the number of shares held, 16% (4) of current holders sold a part of the shares held, and 4% (1) closed the holdings completely. 3 hedge funds are new holders of Entrada Therapeutics, Inc. stock in Q1 2023, it is 12% of total holders.
Hedge funds holding Entrada Therapeutics (Q4 2021 – Q1 2023)
| Q4 2021 | 46 |
|---|---|
| Q1 2022 | 48 |
| Q2 2022 | 36 |
| Q3 2022 | 33 |
| Q4 2022 | 46 |
| Q1 2023 | 25 |
Hedge funds changes in Entrada Therapeutics positions (Q4 2021 – Q1 2023)
| Q4 2021 | 46 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q1 2022 | 8 | 14 | 12 | 6 | 8 |
| Q2 2022 | 7 | 5 | 14 | 18 | -8 |
| Q3 2022 | 5 | 13 | 7 | 8 | 0 |
| Q4 2022 | 16 | 16 | 6 | 3 | 5 |
| Q1 2023 | 3 | 12 | 4 | 1 | 5 |